Higher Amount of Free Circulating DNA in Serum than in Plasma Is Not Mainly Caused by Contaminated Extraneous DNA during Separation

Abstract:  Circulating DNA isolated from serum and plasma has been shown to be a useful biomarker in various diseases including cancer. Serum reportedly contains a higher amount of free circulating DNA than it does in plasma. The underlying reason for this is unclear, but important because it may have clinical implications in interpreting results and using the appropriate resource. Twenty‐four pairs of serum and plasma samples were collected from patients with tumors, and free circulating DNA was quantified by real‐time quantitative PCR (qPCR) for the ALU repeats, which had a sensitivity of 0.1 pg/μL of DNA in serum/plasma. The possibility of DNA loss was eliminated because ALU‐qPCR does not require DNA purification from serum/plasma. The DNA concentrations of serum and plasma samples were 970 ± 730 pg/μL and 180 ± 150 pg/μL (mean ± SD), respectively. The amount of DNA in paired serum and plasma specimens was positively correlated (R= 0.72 and P= 0.0002). An estimated 8.2% of total DNA in serum was extraneous; the concentration of DNA was 6.1 ± 3.5 (mean ± SD)‐fold higher in serum than in paired plasma after subtraction of it. Contribution of extraneous DNA from cells in blood ruptured during the separation step was minor for explaining the difference between serum and plasma. A possible explanation was unequal distribution of DNA during separation from whole blood. We advocate that serum is a better specimen source for circulating cancer‐related DNA as a biomarker.

[1]  A. Kremer,et al.  Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. , 2005, Clinical Chemistry.

[2]  K. C. Chan,et al.  Effects of preanalytical factors on the molecular size of cell-free DNA in blood. , 2005, Clinical chemistry.

[3]  Walter Weder,et al.  Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Elashoff,et al.  Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome , 2004, Cancer Research.

[5]  S. O’Day,et al.  Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients , 2004, Annals of the New York Academy of Sciences.

[6]  D. Hoon,et al.  Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility , 2004, Annals of the New York Academy of Sciences.

[7]  D. Hoon,et al.  Circulating nucleic acids in plasma and serum: past, present and future. , 2004, Current opinion in molecular therapeutics.

[8]  H. Mulcahy,et al.  Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients , 2004, Cancer and Metastasis Reviews.

[9]  A. Nekrutenko,et al.  Densities, length proportions, and other distributional features of repetitive sequences in the human genome estimated from 430 megabases of genomic sequence. , 2000, Gene.

[10]  R F Martin,et al.  General deming regression for estimating systematic bias and its confidence interval in method-comparison studies. , 2000, Clinical chemistry.

[11]  K. Iczkowski,et al.  Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. , 1998, Pancreas.

[12]  J. Jen,et al.  Molecular detection of genetic alterations in the serum of colorectal cancer patients. , 1998, Cancer research.

[13]  M. Farthing,et al.  A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  A. Smit,et al.  The origin of interspersed repeats in the human genome. , 1996, Current opinion in genetics & development.

[15]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[16]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[17]  R. Britten,et al.  Insertion and/or deletion of many repeated DNA sequences in human and higher ape evolution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.